Gene therapy, cell therapy and vaccine research have led to an increased need to perform cellular immunity testing in a regulated environment to ensure the safety and efficacy of these treatments. The most common method for the measurement of cellular immunity has been Enzyme-Linked Immunospot assays. However, there is a lack of regulatory guidance available discussing the recommendations for developing and validating these types of assays. Hence, the Global CRO Council has issued this white paper to provide a consensus on the different validation parameters required to support Enzyme-Linked Immunospot assays and a harmonized and consistent approach to Enzyme-Linked Immunospot validation among contract research organizations.
Keywords:
cell therapy cellular immunity ELISpot Enzyme-Linked Immunospot GCC gene therapy global CRO council regulated bioanalysis vaccine validation
Learn.
Engage.
Connect.
Learn | Engage | Connect
Read news, updates, and transforming technologies of drug development
Webinar Challenges and Solutions
Now Streaming On-Demand Challenges and Solutions Development and Validation of..
Read More ...Large molecule bioanalytical services
Accelerating Drug Development with Somru CRO: Your Trusted Clinical Research..
Read More ...Events
Conference. Webinar. Workshop. and More… Upcoming Previous 19th WRIB Conference..
Read More ...Webinar Challenges & Solutions:
Webinar “Challenges & Solutions: Development and Validation of Abatacept Biosimilar..
Read More ...
